Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rami Yoseph"'
Autor:
Steven A Rosenberg, Maria Parkhurst, Paul Robbins, Nikolaos Zacharakis, Frank Lowery, Sri Krishna, Rami Yoseph, Neilesh Parikh, Sivasish Sindiri, Kyle J Hitscherich, Noam Levin, Aaron Dinerman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/af95ef9b755540c2b0c0694eee5dfd28
Autor:
Steven Rosenberg, Maria Parkhurst, Paul Robbins, Nikolaos Zacharakis, Frank Lowery, Sri Krishna, Rami Yoseph, Neilesh Parikh, Praveen Chatani, Yong-Chen William Lu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d1cbd8b9e12d4103b96e69ab5bb825b8
Autor:
Yong-Chen William Lu, Frank J. Lowery, Rami Yoseph, Maria R. Parkhurst, Praveen D. Chatani, Neilesh Parikh, Nikolaos Zacharakis, Steven A. Rosenberg, Sri Krishna, Paul D. Robbins
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundAutologous patient T cells engineered to express antitumor T cell receptors (TCRs) and chimeric antigen receptors (CARs) have been effective for the treatment of certain cancer types,1–4 and tumor neoantigens encoded by cancer-specific mu
Autor:
Rami Yoseph, Sri Krishna, Frank J. Lowery, Amy R. Copeland, Neilesh B. Parikh, Kyle Hitscherich, Paul F. Robbins, Steven A. Rosenberg
Publikováno v:
Cancer Research. 82:2762-2762
Adoptive cell transfer of gene-engineered lymphocytes expressing T cell receptors (TCRs) targeting tumor antigens has shown promising clinical efficacy for the treatment of advanced cancer patients. For personalized treatment and to minimize “off-t